Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease

NCT00005969 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study withdrawn.

Conditions

Lymphoma

Interventions

DRUG: Chemotherapy
DRUG: Tretinoin Liposome

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]